DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) SHH

17.24

+0.11(+0.64%)

Updated at August 19 01:06PM

Currency In CNY

Valuation

Market Cap17.01B
Enterprise Value17.11B
P/E Ratio20.34
PEG Ratio3.3
Price/Sales Ratio0.73
Price/Book Ratio2.7
Enterprise/Revenue0.69
Enterprise/EBITDA9.49

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.04
Operating Margin0.06

Management Effectiveness

Return On Assets0.04
Return On Equity0.14

Income Statement

Revenue26.5B
Revenue/Share23.17
Gross Profit9.1B
EBITDA3.03B
Net Income914.75M
Diluted EPS0.81

Balance Sheet

Total Cash6.74B
Total Cash/Share5.86
Total Debt5.65B
Total Debt/Equity0.77
Current Ratio0.97
Book Value Per Share7.51

Price History

52-Week Change31.63
52-Week High19
52-Week Low11.92
Moving Average 50 Days16.87
Moving Average 200 Days16.18

Statistics

Average Volume6.03M
Shares Outstanding1.13B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.62
Trailing Annual Dividend Yield3.59
Payout Ratio0.77
Last Split Factor6:5
Last Split DateJune 09, 2023